Anatomical Therapeutic Chemical (ATC) Classification

[ Brite menu | Download htext | Download json | Help ]
Search

1st Level  2nd Level  3rd Level  4th Level  5th Level  6th Level 

 A ALIMENTARY TRACT AND METABOLISM
 
 B BLOOD AND BLOOD FORMING ORGANS
 
 C CARDIOVASCULAR SYSTEM
 
 D DERMATOLOGICALS
 
 G GENITO URINARY SYSTEM AND SEX HORMONES
 
 H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
 
 J ANTIINFECTIVES FOR SYSTEMIC USE
 
 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
 
 M MUSCULO-SKELETAL SYSTEM
 
 N NERVOUS SYSTEM
   N01 ANESTHETICS
   N02 ANALGESICS
     N02A OPIOIDS
     N02B OTHER ANALGESICS AND ANTIPYRETICS
     N02C ANTIMIGRAINE PREPARATIONS
       N02CA Ergot alkaloids
         N02CA01 Dihydroergotamine [DG:DG00833]
         N02CA02 Ergotamine [DG:DG00834]
           D07906  Ergotamine (INN)
           D00679  Ergotamine tartrate (JP18/USP) <US>
         N02CA04 Methysergide [DG:DG00835]
         N02CA07 Lisuride [DG:DG00453]
         N02CA51 Dihydroergotamine, combinations
         N02CA52 Ergotamine, combinations excl. psycholeptics
         N02CA72 Ergotamine, combinations with psycholeptics
       N02CB Corticosteroid derivatives
       N02CC Selective serotonin (5HT1) agonists [DG:DG01943]
       N02CD Calcitonin gene-related peptide (CGRP) antagonists
       N02CX Other antimigraine preparations
   N03 ANTIEPILEPTICS
   N04 ANTI-PARKINSON DRUGS
   N05 PSYCHOLEPTICS
   N06 PSYCHOANALEPTICS
   N07 OTHER NERVOUS SYSTEM DRUGS
 
 P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
 
 R RESPIRATORY SYSTEM
 
 S SENSORY ORGANS
 
 V VARIOUS

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: July 2, 2025
According to WHO's ATC 2025

» Japanese version